Search
for
Sort by
Research 901–930 of 1000+
- Cutaneous Lupus Erythematosus
- Teriflunomide efficacy, safety and tolerability in patients with relapsing forms of multiple sclerosis
- IN OTHER JOURNALS
- An Analysis of the Correlation between Alopecia and Chief Complaints
- Therapies
- New Drugs: Dutasteride
- Clinical Management in Psychodermatology
- Drugs that affect autonomic functions or the extrapyramidal system
- Alopecia
- Abstracts Pt.30
- NEW PROPRIETARY BRANDS: Gabapentin
- New drugs: Agalsidase beta
- NEW FORMULATIONS: Sodium cromoglycate
- Letter to the Editor Etiquette
- Antiulcer drugs
- Drug Information Analysis Service
- Cutaneous manifestations of systemic infection in children
- Dermatological drugs, topical agents, and cosmetics
- Cytostatics and immunosuppressive drugs
- PHILADELPHIA DERMATOLOGICAL SOCIETY
- Efficacy and safety of platelet rich plasma therapy in male androgenetic alopecia
- Hair loss is a symptom of many complex medical and psychological problems
- Cephalalgic Alopecia Areata
- Traumatic scalp arteriovenous fistula post capillary implantation successfully treated using PHIL embolic agent
- Balint’s syndrome—missed or mistaken?
- Hair loss due to methylphenidate use: A case study
- Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C
- Alopecia induced by lopinavir plus ritonavir therapy in an HIV patient.
- Self-Reported Hair Loss Following COVID-19: An Observational Study
- Symptoms: Pruritic Skin Lesions